Document is current
Any future updates will be listed below
-
Authors
Wu, Lili
Zheng, Anqi
Tang, Yangming
Chai, Yan
Chen, Jiantao
Cheng, Lin
Hu, Yu
Qu, Jing
Lei, Wenwen
Liu, William Jun
Wu, Guizhen
Zeng, Shaogui
Yang, Hang
Wang, Qihui
Gao, George Fu
- License Information
-
More Information
Article History
Received: 10 April 2023
Accepted: 5 July 2023
First Online: 11 August 2023
Ethics
: <b>Compliance and ethics</b> G.F.G., Q.W., S.Z., L.W., A.Z., Y.T., Y.C., and J.C. are listed as the coinventors of the patents for the peptide fusion inhibitors described in this study. S.Z. is a founder of Hybio Pharmaceutical Co., Ltd., and Y. T. and J.C. are employees of this company. Other authors declare no conflict of interest. All animal experiments in this study were approved by the Institutional Animal Care and Use Committee (No.: WIVA17202005) in Wuhan Institute of Virology, CAS. All authors state that they conformed with the Helsinki Declaration of 1975 concerning Human and Animal Rights.
